We are delighted to announce that Accel-Heal Solo has been awarded the Emirates Health Services (EHS) tender for the provision of electrical stimulation therapy for wound care.
This follows a successful clinical evaluation and a thorough review of the scientific, clinical, and health economic evidence supporting the use of Accel-Heal Solo in accelerating the healing of hard-to-heal wounds such as diabetic foot ulcers.
EHS is the UAE’s federal healthcare provider, overseeing a network of 17 hospitals, over 70 primary healthcare centres, and a total of 134 facilities serving communities across Sharjah, Ajman, Umm Al Quwain, Ras Al Khaimah, and Fujairah. Being selected by EHS is a strong endorsement of Accel-Heal Solo’s clinical impact and value in transforming wound care outcomes.
This award represents a major step forward in our mission to expand access to Accel-Heal Solo for patients who need it most and reflects our commitment to working with world-class healthcare systems to deliver innovative, evidence-based solutions.
We are proud to collaborate with Razan Medical Trading, our distribution partner in the UAE, who continue to support EHS with medical education, clinician training, and expert implementation across the region.
“We are proud to support Emirates Health Services in bringing Accel-Heal Solo to clinicians and patients across the UAE, following years of successful use by vascular and wound care teams. This tender win reflects our shared commitment to introducing proven, evidence-based innovations that genuinely improve outcomes in wound care. Through ongoing training and education, we aim to empower healthcare professionals to deliver the best possible care using this transformative technology.”
Hussain Malkawi, Managing Director, Razan Medical Trading